{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:17:15Z","timestamp":1778822235209,"version":"3.51.4"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1124\/jpet.120.000196","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:32:40Z","timestamp":1604709160000},"page":"161-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prostanoid Receptors of the EP4-Subtype Mediate Gene Expression Changes in Human Airway Epithelial Cells with Potential Anti-Inflammatory Activity"],"prefix":"10.1016","volume":"376","author":[{"given":"Radhika","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubrey N.","family":"Michi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahina","family":"Wiehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-8498","authenticated-orcid":false,"given":"Robert","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Giembycz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000196_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1388-1981(99)00164-X","article-title":"The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs","volume":"1483","author":"Abramovitz","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.120.000196_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pupt.2017.11.001","article-title":"Activating prostaglandin E2 receptor subtype EP4 increases secreted mucin from airway goblet cells","volume":"48","author":"Akaba","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/jpet.120.000196_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/jpet.107.129312","volume":"324","author":"Ayer","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000196_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lungcan.2016.09.011","article-title":"Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLC","volume":"101","author":"Bhooshan","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1124\/jpet.120.000196_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/mol.114.093393","article-title":"Superiority of combined phosphodiesterase PDE3\/PDE4 inhibition over PDE4 inhibition alone on glucocorticoid- and long-acting \u03b22-adrenoceptor agonist-induced gene expression in human airway epithelial cells","volume":"87","author":"BinMahfouz","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/thoraxjnl-2014-206592","article-title":"Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype","volume":"70","author":"Birrell","year":"2015","journal-title":"Thorax"},{"key":"10.1124\/jpet.120.000196_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bjp.0706554","article-title":"RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists","volume":"147","author":"Bley","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00210-013-0950-4","article-title":"Non-raft adenylyl cyclase 2 defines a cAMP signaling compartment that selectively regulates IL-6 expression in airway smooth muscle cells: differential regulation of gene expression by AC isoforms","volume":"387","author":"Bogard","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib10","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1073\/pnas.0510562103","article-title":"Role of \u03b2-arrestin 1 in the metastatic progression of colorectal cancer","volume":"103","author":"Buchanan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.120.000196_bib11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thx.2010.158568","article-title":"EP4 receptor as a new target for bronchodilator therapy","volume":"66","author":"Buckley","year":"2011","journal-title":"Thorax"},{"key":"10.1124\/jpet.120.000196_bib12","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1111\/j.1432-1033.2004.04342.x","article-title":"Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E release","volume":"271","author":"Chivers","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1124\/jpet.120.000196_bib13","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1074\/jbc.M506770200","article-title":"Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling","volume":"281","author":"Cho","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000196_bib14","doi-asserted-by":"crossref","first-page":"39672","DOI":"10.1074\/jbc.M110.117689","article-title":"The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and \u03b2-arrestin1-dependent signaling pathways","volume":"285","author":"Chun","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000196_bib15","doi-asserted-by":"crossref","first-page":"L238","DOI":"10.1152\/ajplung.00313.2004","article-title":"Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor","volume":"288","author":"Clarke","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.120.000196_bib16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41388-018-0492-9","article-title":"Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis","volume":"38","author":"Coburn","year":"2019","journal-title":"Oncogene"},{"key":"10.1124\/jpet.120.000196_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2125.1985.tb05077.x","article-title":"Characteristics of prostaglandin induced cough in man","volume":"20","author":"Costello","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0092-8674(92)90429-G","article-title":"The growth arrest-specific gene, GAS1, is involved in growth suppression","volume":"70","author":"Del Sal","year":"1992","journal-title":"Cell"},{"key":"10.1124\/jpet.120.000196_bib19","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1073\/pnas.0801319105","article-title":"Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors","volume":"105","author":"Einstein","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.120.000196_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1165\/rcmb.2007-0438OC","article-title":"16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis","volume":"41","author":"Failla","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.120.000196_bib21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/thoraxjnl-2017-211097","article-title":"Facilitation of IL-22 production from innate lymphoid cells by prostaglandin E2 prevents experimental lung neutrophilic inflammation","volume":"73","author":"Felton","year":"2018","journal-title":"Thorax"},{"key":"10.1124\/jpet.120.000196_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1165\/rcmb.2015-0373OC","article-title":"Phosphodiesterase 4 inhibitors attenuate the asthma phenotype produced by \u03b22-adrenoceptor agonists in phenylethanolamine N-methyltransferase-knockout mice","volume":"55","author":"Forkuo","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.120.000196_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0165-6147(03)00162-7","article-title":"Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?","volume":"24","author":"Fujino","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.120.000196_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1124\/mol.105.017749","article-title":"EP4 prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein","volume":"69","author":"Fujino","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccm.2013.09.007","article-title":"How phosphodiesterase 4 inhibitors work in patients with chronic obstructive pulmonary disease of the severe, bronchitic, frequent exacerbator phenotype","volume":"35","author":"Giembycz","year":"2014","journal-title":"Clin Chest Med"},{"key":"10.1124\/jpet.120.000196_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.12703\/P7-16","article-title":"Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseases","volume":"7","author":"Giembycz","year":"2015","journal-title":"F1000Prime Rep"},{"key":"10.1124\/jpet.120.000196_bib27","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/bph.13565","article-title":"The anti-inflammatory effects of PGE2 on human lung macrophages are mediated by the EP4 receptor","volume":"173","author":"Gill","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12931-020-1329-y","article-title":"Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis","volume":"21","author":"Govoni","year":"2020","journal-title":"Respir Res"},{"key":"10.1124\/jpet.120.000196_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/mol.66.2.337","article-title":"Interleukin-1\u03b2-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling","volume":"66","author":"Gray","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/jpet.113.206284","article-title":"Concurrent agonism of adenosine A2B and glucocorticoid receptors in human airway epithelial cells cooperatively induces genes with anti-inflammatory potential: a novel approach to treat chronic obstructive pulmonary disease","volume":"346","author":"Greer","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000196_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2172-13-57","article-title":"Quantitative GPCR and ion channel transcriptomics in primary alveolar macrophages and macrophage surrogates","volume":"13","author":"Groot-Kormelink","year":"2012","journal-title":"BMC Immunol"},{"key":"10.1124\/jpet.120.000196_bib32","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1016\/S0021-9258(19)45905-X","article-title":"On the metabolism of prostaglandins E1 and E2 in man","volume":"246","author":"Hamberg","year":"1971","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000196_bib33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40266-019-00647-y","article-title":"Idiopathic pulmonary fibrosis: new and emerging treatment options","volume":"36","author":"Hewitt","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1124\/jpet.120.000196_bib34","doi-asserted-by":"crossref","first-page":"19713","DOI":"10.1073\/pnas.1110226108","article-title":"\u03b22-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids","volume":"108","author":"Holden","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.120.000196_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/jpet.113.204586","article-title":"Induction of regulator of G-protein signaling 2 expression by long-acting \u03b22-adrenoceptor agonists and glucocorticoids in human airway epithelial cells","volume":"348","author":"Holden","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000196_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1513\/pats.200603-059MS","article-title":"Exacerbation of chronic obstructive pulmonary disease: pan-airway and systemic inflammatory indices","volume":"3","author":"Hurst","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1124\/jpet.120.000196_bib37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.120.000196_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejpb.2012.11.023","article-title":"Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2","volume":"84","author":"Ivanova","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.120.000196_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tips.2013.05.003","article-title":"Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection","volume":"34","author":"Jiang","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.120.000196_bib40","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1073\/pnas.1120195109","article-title":"Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2","volume":"109","author":"Jiang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.120.000196_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/mol.117.110825","article-title":"cAMP signaling compartmentation: adenylyl cyclases as anchors of dynamic signaling complexes","volume":"93","author":"Johnstone","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.plefa.2004.12.002","article-title":"Investigation of the agonist activity of prostacyclin analogues on prostanoid EP4 receptors using GW 627368 and taprostene: evidence for species differences","volume":"72","author":"Jones","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1124\/jpet.120.000196_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/mol.118.115311","article-title":"Impact of phosphodiesterase 4 inhibition on the operational efficacy, response maxima, and kinetics of indacaterol-induced gene expression changes in BEAS-2B airway epithelial cells: a global transcriptomic analysis","volume":"96","author":"Joshi","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib44","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/bph.13014","article-title":"An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics","volume":"172","author":"Joshi","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib45","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/bph.13087","article-title":"The long-acting \u03b22-adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner","volume":"172","author":"Joshi","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/jpet.116.237743","article-title":"GS-5759, a bifunctional \u03b22-adrenoceptor agonist and phosphodiesterase 4 inhibitor for chronic obstructive pulmonary disease with a unique mode of action: effects on gene expression in human airway epithelial cells","volume":"360","author":"Joshi","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000196_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1165\/rcmb.2006-0295OC","article-title":"8-iso-PGE2 stimulates anion efflux from airway epithelial cells via the EP4 prostanoid receptor","volume":"38","author":"Joy","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.120.000196_bib48","series-title":"A Pharmacology Primer","first-page":"1076","article-title":"How different tissues process drug responses","author":"Kenakin","year":"2014"},{"key":"10.1124\/jpet.120.000196_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.109.156398","article-title":"Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands","volume":"331","author":"Leduc","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000196_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1084\/jem.20040104","article-title":"Early growth response gene 1-mediated apoptosis is essential for transforming growth factor \u03b21-induced pulmonary fibrosis","volume":"200","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.120.000196_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bjp.0707372","article-title":"Good statistical practice in pharmacology. Problem 2","volume":"152","author":"Lew","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pupt.2010.10.009","article-title":"Activation of the EP4 prostanoid receptor induces prostaglandin E2 and pro-inflammatory cytokine production in human airway epithelial cells","volume":"24","author":"Li","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/jpet.120.000196_bib53","first-page":"7332","article-title":"DEPDC7 inhibits cell proliferation, migration and invasion in hepatoma cells","volume":"14","author":"Liao","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1124\/jpet.120.000196_bib54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0026-895X(24)23047-9","article-title":"Prostaglandin receptor EP4 mediates the bone anabolic effects of PGE2","volume":"60","author":"Machwate","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib55","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1164\/rccm.200903-0388OC","article-title":"Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy","volume":"180","author":"Maher","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.120.000196_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drudis.2016.08.003","article-title":"Structural features of subtype-selective EP receptor modulators","volume":"22","author":"Markovi\u010d","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.120.000196_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.bjp.0701360","article-title":"Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-\u03b1 generation","volume":"122","author":"Meja","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib58","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/jpet.103.060020","article-title":"Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89","volume":"309","author":"Meja","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000196_bib59","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1124\/mol.112.083493","volume":"83","author":"Moodley","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib60","doi-asserted-by":"crossref","unstructured":"Mostafa MM, Rider CF, Wathugala ND, Leigh R, Giembycz MA and Newton R (2020) Transcriptome-level interactions between budesonide and formoterol provide insight into the mechanism of action of ICS\/LABA combination therapy in asthma. Mol Pharmacol. in press .other","DOI":"10.1124\/molpharm.120.000146"},{"key":"10.1124\/jpet.120.000196_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/365166a0","article-title":"Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity","volume":"365","author":"Namba","year":"1993","journal-title":"Nature"},{"key":"10.1124\/jpet.120.000196_bib62","doi-asserted-by":"crossref","first-page":"16122","DOI":"10.1074\/jbc.270.27.16122","article-title":"Selective coupling of prostaglandin E receptor EP3D to Gi and Gs through interaction of alpha-carboxylic acid of agonist and arginine residue of seventh transmembrane domain","volume":"270","author":"Negishi","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000196_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-5793(96)01468-8","article-title":"The C-terminal domain of the Gs-coupled EP4 receptor confers agonist-dependent coupling control to Gi but no coupling to Gs in a receptor hybrid with the Gi-coupled EP3 receptor","volume":"401","author":"Neusch\u00e4fer-Rube","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.120.000196_bib64","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1111\/bph.13628","article-title":"Understanding how long-acting \u03b22-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update","volume":"173","author":"Newton","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib65","doi-asserted-by":"crossref","first-page":"21645","DOI":"10.1074\/jbc.274.31.21645","article-title":"Identification of thioredoxin-binding protein-2\/vitamin D3 up-regulated protein 1 as a negative regulator of thioredoxin function and expression","volume":"274","author":"Nishiyama","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.120.000196_bib66","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1111\/bph.13331","article-title":"Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?","volume":"172","author":"O\u2019Callaghan","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib67","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.bmcl.2016.03.110","article-title":"Structural optimization and structure-functional selectivity relationship studies of G protein-biased EP2 receptor agonists","volume":"26","author":"Ogawa","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.120.000196_bib68","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1021\/acsmedchemlett.5b00455","article-title":"Discovery of G protein-biased EP2 receptor agonists","volume":"7","author":"Ogawa","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/jpet.120.000196_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.08.001","article-title":"Prostaglandins in asthma and allergic diseases","volume":"193","author":"Peebles","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.120.000196_bib70","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.00092506","article-title":"Inflammatory changes, recovery and recurrence at COPD exacerbation","volume":"29","author":"Perera","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.120.000196_bib71","doi-asserted-by":"crossref","first-page":"e40762","DOI":"10.1371\/journal.pone.0040762","article-title":"Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genes","volume":"7","author":"Proud","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000196_bib72","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-065X.2011.01033.x","article-title":"Epithelial cells and airway diseases","volume":"242","author":"Proud","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1124\/jpet.120.000196_bib73","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1183\/09031936.00131606","article-title":"Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-\u03b1 release from human alveolar macrophages","volume":"29","author":"Ratcliffe","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.120.000196_bib74","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1124\/mol.118.112755","article-title":"Long-acting \u03b22-adrenoceptor agonists enhance glucocorticoid receptor (GR)-mediated transcription by gene-specific mechanisms rather than generic effects via GR","volume":"94","author":"Rider","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.120.000196_bib75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12931-018-0759-2","article-title":"The inhibition of human lung fibroblast proliferation and differentiation by Gs-coupled receptors is not predicted by the magnitude of cAMP response","volume":"19","author":"Roberts","year":"2018","journal-title":"Respir Res"},{"key":"10.1124\/jpet.120.000196_bib76","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/14728222.2017.1279146","article-title":"The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases","volume":"21","author":"Rodr\u00edguez-Calvo","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"10.1124\/jpet.120.000196_bib77","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1210\/mend.13.11.0379","article-title":"p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells","volume":"13","author":"Samuelsson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.120.000196_bib78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1165\/rcmb.2009-0361OC","article-title":"Prostaglandin E2 regulation of cystic fibrosis transmembrane conductance regulator activity and airway surface liquid volume requires gap junctional communication","volume":"44","author":"Scheckenbach","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.120.000196_bib79","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1527-3466.1993.tb00202.x","article-title":"Taprostene sodium","volume":"11","author":"Schneider","year":"1993","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1124\/jpet.120.000196_bib80","doi-asserted-by":"crossref","first-page":"e0207872","DOI":"10.1371\/journal.pone.0207872","article-title":"Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors","volume":"13","author":"Sieber","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/jpet.120.000196_bib81","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ni.1637","article-title":"A critical function for CD200 in lung immune homeostasis and the severity of influenza infection","volume":"9","author":"Snelgrove","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.120.000196_bib82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.lfs.2003.09.002","article-title":"Functional domains essential for Gs activity in prostaglandin EP2 and EP3 receptors","volume":"74","author":"Sugimoto","year":"2003","journal-title":"Life Sci"},{"key":"10.1124\/jpet.120.000196_bib83","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/endo.141.4.7405","article-title":"The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs","volume":"141","author":"Suzawa","year":"2000","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.120.000196_bib84","doi-asserted-by":"crossref","first-page":"L127","DOI":"10.1152\/ajplung.2001.280.1.L127","article-title":"Prostaglandin E2-induced interleukin-6 release by a human airway epithelial cell line","volume":"280","author":"Tavakoli","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.120.000196_bib85","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"key":"10.1124\/jpet.120.000196_bib86","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.120.000196_bib87","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.4049\/jimmunol.0802348","article-title":"The novel lipopolysaccharide-binding protein CRISPLD2 is a critical serum protein to regulate endotoxin function","volume":"183","author":"Wang","year":"2009","journal-title":"J Immunol"},{"key":"10.1124\/jpet.120.000196_bib88","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0024-3205(78)90096-6","article-title":"Kinetic and empirical analysis of dose-response curves illustrated with a cardiac example","volume":"22","author":"Waud","year":"1978","journal-title":"Life Sci"},{"key":"10.1124\/jpet.120.000196_bib89","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.4049\/jimmunol.0902738","article-title":"Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells","volume":"183","author":"Wilson","year":"2009","journal-title":"J Immunol"},{"key":"10.1124\/jpet.120.000196_bib90","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/jpet.118.249292","article-title":"Analysis of the indacaterol-regulated transcriptome in human airway epithelial cells implicates gene expression changes in the adverse and therapeutic effects of \u03b22-adrenoceptor agonists","volume":"366","author":"Yan","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000196_bib91","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.201210-1886OC","article-title":"Glucocorticoid-induced changes in gene expression of airway smooth muscle in patients with asthma","volume":"187","author":"Yick","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.120.000196_bib92","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/pr.112.007195","article-title":"The prostanoid EP4 receptor and its signaling pathway","volume":"65","author":"Yokoyama","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.120.000196_bib93","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/jpet.120.000196_bib94","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3987\/COM-04-S(P)47","article-title":"Discovery and synthesis of a potent, selective and orally bioavailable EP4 receptor agonist","volume":"64","author":"Young","year":"2004","journal-title":"Heterocycles"},{"key":"10.1124\/jpet.120.000196_bib95","doi-asserted-by":"crossref","first-page":"e12942","DOI":"10.14814\/phy2.12942","article-title":"CRISPLD2 (LGL1) inhibits proinflammatory mediators in human fetal, adult, and COPD lung fibroblasts and epithelial cells","volume":"4","author":"Zhang","year":"2016","journal-title":"Physiol Rep"},{"key":"10.1124\/jpet.120.000196_bib96","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fimmu.2018.00501","article-title":"Prostaglandin E2 inhibits group 2 innate lymphoid cell activation and allergic airway inflammation through E-prostanoid 4-cyclic adenosine monophosphate signaling","volume":"9","author":"Zhou","year":"2018","journal-title":"Front Immunol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524257529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:16:49Z","timestamp":1739963809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524257529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0022356524257529"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000196","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostanoid Receptors of the EP4-Subtype Mediate Gene Expression Changes in Human Airway Epithelial Cells with Potential Anti-Inflammatory Activity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}